SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-19-030084
Filing Date
2019-08-07
Accepted
2019-08-07 16:17:20
Documents
4
Effectiveness Date
2019-08-07

Document Format Files

Seq Description Document Type Size
1 S-8 sndx-s8.htm S-8 90351
2 EX-5.1 sndx-ex51_50.htm EX-5.1 7824
3 EX-23.1 sndx-ex231_7.htm EX-23.1 2830
4 GRAPHIC gyhmbaz3u0vb000001.jpg GRAPHIC 28720
  Complete submission text file 0001564590-19-030084.txt   141735
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-233083 | Film No.: 191005709
SIC: 2834 Pharmaceutical Preparations